TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 788820

Group type: EXPERIMENTAL
Intervention: 1 g ascorbic acid per day
Number of subjects: 688

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 688
Study: 30741103

Group type: EXPERIMENTAL
Intervention: modified Story Memory Technique (mSMT) training, twice per week for 5 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo control (non-training-oriented tasks)
Number of subjects: 30
Study: 31289068

Group type: EXPERIMENTAL
Intervention: Amoxicillin/clavulanic acid suspension (intervention)
Number of subjects: 550

Group type: COMPARATOR
Intervention: Intravenous therapy for another 5 days (control)
Number of subjects: 550
Study: 27302626

Group type: EXPERIMENTAL
Intervention: RBCs stored 1‐10 days
Number of subjects: 147

Group type: COMPARATOR
Intervention: RBCs stored 25‐35 days
Number of subjects: 147
Study: 25952047

Group type: EXPERIMENTAL
Intervention: Empowerment tool for infection control
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal practices (Control)
Number of subjects: 60
Study: 23456136

Group type: EXPERIMENTAL
Intervention: Musculoskeletal ultrasound (M-US) measurements of muscle thickness, pennation angle, and echogenicity of musculus quadriceps
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Thickness of musculus vastus medialis measured by M-US
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: M-US measurements of muscle thickness
Number of subjects: 52
Study: 21299401

Group type: EXPERIMENTAL
Intervention: 3 days of continuous glucose monitoring
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: 15 days of continuous glucose monitoring
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: 12-15 days of monitoring every 3 months
Number of subjects: 185
Study: 19896062

Group type: EXPERIMENTAL
Intervention: Zirconia head
Number of subjects: 62

Group type: COMPARATOR
Intervention: Cobalt-chromium head
Number of subjects: 62
Study: 16741302

Group type: EXPERIMENTAL
Intervention: (11)C‐choline PET
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Contrast-enhanced CT
Number of subjects: 27

Group type: COMPARATOR
Intervention: Both modalities
Number of subjects: 27
Study: 15635998

Group type: EXPERIMENTAL
Intervention: High-frequency chest compression (HFCC)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard chest physical therapy (CPT)
Number of subjects: 12
Study: 11760478

Group type: EXPERIMENTAL
Intervention: Propofol-MCT/LCT
Number of subjects: 184

Group type: COMPARATOR
Intervention: Propofol-LCT
Number of subjects: 184
Study: 9433788

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 8353361

Group type: EXPERIMENTAL
Intervention: Diet containing 16.5 g of fish oil in 1500 ml (Impact)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Usual care (standard enteral formulas devoid of fish oil)
Number of subjects: 16
Study: 3071872

Group type: EXPERIMENTAL
Intervention: Transanal endoscopic microsurgery
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Local surgery alone for pT1 carcinoma
Number of subjects: 140
Study: 31010445

Group type: EXPERIMENTAL
Intervention: Vortioxetine (flexible doses of 10/20 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Escitalopram (flexible doses of 10/20 mg)
Number of subjects: 0
Study: 30239857

Group type: EXPERIMENTAL
Intervention: nIPPV
Number of subjects: 84

Group type: COMPARATOR
Intervention: nCPAP
Number of subjects: 84
Study: 28829518

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (MM)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 35
Study: 25344794

Group type: EXPERIMENTAL
Intervention: VocSyl
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Pacing Board
Number of subjects: 18

Group type: COMPARATOR
Intervention: Active Control Group
Number of subjects: 18
Study: 24321337

Group type: EXPERIMENTAL
Intervention: Wii Fit Plus (12 weeks)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control group (routine care for 12 weeks, then Wii Fit Plus)
Number of subjects: 220
Study: 21217529

Group type: EXPERIMENTAL
Intervention: CKCE (sling-based exercises)
Number of subjects: 26

Group type: COMPARATOR
Intervention: OKCE (traditional exercises)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both CKCE and OKCE
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: CKCE and OKCE
Number of subjects: 26
Study: 19820745

Group type: EXPERIMENTAL
Intervention: Teaching critical appraisal skills in dental schools
Number of subjects: 0
Study: 21586199

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 17

Group type: COMPARATOR
Intervention: Rituximab
Number of subjects: 17
Study: 15621485

Group type: EXPERIMENTAL
Intervention: Small calibre (19F), flexible, fluted spiral drains with round cross-section (group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard chest drains (group B)
Number of subjects: 100
Study: 11810082

Group type: EXPERIMENTAL
Intervention: ethinyl estradiol/desogestrel
Number of subjects: 35

Group type: COMPARATOR
Intervention: ethinyl estradiol/levonorgestrel
Number of subjects: 35
Study: 9666171

Group type: EXPERIMENTAL
Intervention: Capsaicin cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 0
Study: 7666013

Group type: EXPERIMENTAL
Intervention: PHFO-diet
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: PHSO-diet
Number of subjects: 31

Group type: COMPARATOR
Intervention: butter-diet
Number of subjects: 31
Study: 2669154

Group type: EXPERIMENTAL
Intervention: 2 gm of intravenous cefotetan after forceps delivery
Number of subjects: 393

Group type: COMPARATOR
Intervention: No antibiotics
Number of subjects: 393
Study: 301428

Group type: EXPERIMENTAL
Intervention: Immunized groups
Number of subjects: 55

Group type: COMPARATOR
Intervention: Nonimmunized groups
Number of subjects: 55
Study: 11098941

Group type: EXPERIMENTAL
Intervention: Carotid pulse check during pulsatile (spontaneous) circulation
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Carotid pulse check during nonpulsatile (extracorporeal) circulation
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Advanced training level
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Basic cardiopulmonary resuscitation training
Number of subjects: 206
Study: 31688452

Group type: EXPERIMENTAL
Intervention: Valbenazine 40 mg/d
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Valbenazine 80 mg/d
Number of subjects: 152
Study: 30138014

Group type: EXPERIMENTAL
Intervention: Individual cognitive-behavioral therapy (ICBT)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral therapy (GCBT)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Wait list (WL)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Group cognitive-behavioral therapy (GCBT) for children diagnosed with social anxiety disorder (SOC)
Number of subjects: 165
Study: 26888149

Group type: EXPERIMENTAL
Intervention: Higher-dose edoxaban (60 mg)
Number of subjects: 1943

Group type: EXPERIMENTAL
Intervention: Lower-dose edoxaban (30 mg)
Number of subjects: 1943

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 1943
Study: 25251294

Group type: EXPERIMENTAL
Intervention: Dark chocolate (DARK)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Oat β‐glucan and dark chocolate (B‐GLU + DARK)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Milk chocolate (CON)
Number of subjects: 25
Study: 21585523

Group type: EXPERIMENTAL
Intervention: Naftazone (titrated up to 120 mg/day)
Number of subjects: 7
Study: 21067351

Group type: EXPERIMENTAL
Intervention: Inactivated trivalent seasonal influenza vaccine (TIV)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Seasonal influenza A infection
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Seasonal TIV
Number of subjects: 119
Study: 17996568

Group type: EXPERIMENTAL
Intervention: F-18-fluorodeoxyglucose (FDG) PET-assisted management
Number of subjects: 430

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: F-18-fluorodeoxyglucose (FDG) PET-assisted management (adhered to recommendations)
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: F-18-fluorodeoxyglucose (FDG) PET-assisted management (without recent angiography)
Number of subjects: 430
Study: 14962151

Group type: EXPERIMENTAL
Intervention: Tramadol 37.5 mg/acetaminophen 325 mg combination tablets (tramadol/APAP)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study: 11668378

Group type: EXPERIMENTAL
Intervention: Chronic venous insufficiency patients (group I)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control subjects (group II)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 9
Study: 9689909

Group type: EXPERIMENTAL
Intervention: List composition (common vs. unusual verbal information)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hybrid model incorporating intralist and extralist sources of distinctiveness and expectation-violating mechanism
Number of subjects: 0
Study: 8130041

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% 1 ml kg-1 + Clonidine 2 micrograms kg-1 in normal saline 1 ml (Group B)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Bupivacaine 0.25% 1 ml kg-1 + Normal saline 1 ml (Group A)
Number of subjects: 46
Study: 2573228

Group type: EXPERIMENTAL
Intervention: Epidural morphine
Number of subjects: 22

Group type: COMPARATOR
Intervention: Systemic opioids
Number of subjects: 22
Study: 1104655

Group type: EXPERIMENTAL
Intervention: Live, attenuated, influenza type A (H3N2) vaccine (Alice)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 30064455

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid together with 10 × 106 cultured autologous bone marrow-derived MSCs (Low-dose)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid together with 100 × 106 cultured autologous bone marrow-derived MSCs (High-dose)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hyaluronic acid alone (Control)
Number of subjects: 30
Study: 28801071

Group type: EXPERIMENTAL
Intervention: Spinal Manipulation Therapy (SMT)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Spinal Mobilization (MOB)
Number of subjects: 92

Group type: COMPARATOR
Intervention: No Treatment (REST)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Subgroup analysis of TSP clusters
Number of subjects: 92
Study: 25148887

Group type: EXPERIMENTAL
Intervention: Biliopancreatic diversion (BPD)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Lean-control group
Number of subjects: 31

Group type: COMPARATOR
Intervention: Obese-control group
Number of subjects: 31
Study: 23075062

Group type: EXPERIMENTAL
Intervention: Fixed lingual appliances (Stealth®, AO, Sheboygan, Wisc)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional fixed labial appliances
Number of subjects: 34
Study: 21349184

Group type: EXPERIMENTAL
Intervention: Mindfulness-based psychological intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study: 18469276

Group type: EXPERIMENTAL
Intervention: Diet with oat and wheat bread and potato (high postprandial insulin response)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Diet with rye bread and pasta (low postprandial insulin response)
Number of subjects: 47
Study: 16563975

Group type: EXPERIMENTAL
Intervention: everolimus 1.5 mg twice daily (n = 101)
Number of subjects: 213

Group type: COMPARATOR
Intervention: azathioprine 1 to 3 mg/kg/day (n = 112)
Number of subjects: 213
Study: 12112884

Group type: EXPERIMENTAL
Intervention: Sheath introducer with hydrophilic coating
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sheath introducer without hydrophilic coating
Number of subjects: 73
Study: 10349694

Group type: EXPERIMENTAL
Intervention: Combination therapy with ribavirin and rIFN-alpha 2b
Number of subjects: 2089

Group type: COMPARATOR
Intervention: rIFN-alpha 2b alone
Number of subjects: 2089
Study: 7717480

Group type: EXPERIMENTAL
Intervention: Midazolam 0.1 mg.kg‐1 by intramuscular injection as premedication
Number of subjects: 83

Group type: COMPARATOR
Intervention: Alfentanil-nitrous oxide anaesthesia without midazolam premedication (previous study)
Number of subjects: 83
Study: 2149533

Group type: EXPERIMENTAL
Intervention: Piroxicam 1% cream (38 patients)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Diclofenac 1% emulgel (37 patients)
Number of subjects: 75
Study: 7361826

Group type: EXPERIMENTAL
Intervention: Independence training
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 75

Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 75
Study: 31433893

Group type: COMPARATOR
Intervention: Patient-Controlled Analgesia (PCA)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Serratus Anterior Plane Block (SAPB)
Number of subjects: 89
Study: 29789868

Group type: EXPERIMENTAL
Intervention: Simulated rhinoplasty result
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Actual rhinoplasty result
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nasal tip projection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nasal tip rotation
Number of subjects: 40
Study: 28818053

Group type: EXPERIMENTAL
Intervention: Computer-assisted self-interviews (CASI)
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Audio-CASI
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Self-interview methods (CASI and audio-CASI)
Number of subjects: 504

Group type: COMPARATOR
Intervention: Interviewer-led interviews (CAPI)
Number of subjects: 504

Group type: COMPARATOR
Intervention: Paper-and-pen-interview
Number of subjects: 504
Study: 25935875

Group type: EXPERIMENTAL
Intervention: Ticagrelor treatment
Number of subjects: 4990
Study: 24156396

Group type: EXPERIMENTAL
Intervention: EPIC Wheels program
Number of subjects: 40

Group type: COMPARATOR
Intervention: Computer-game control group
Number of subjects: 40
Study: 21127303

Group type: EXPERIMENTAL
Intervention: Alteplase
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99

Group type: COMPARATOR
Intervention: Alteplase vs Placebo
Number of subjects: 99
Study: 18495880

Group type: EXPERIMENTAL
Intervention: Naloxone (opioid antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 0
Study: 16790053

Group type: EXPERIMENTAL
Intervention: Structured welfare rights assessment followed by active assistance with welfare benefit claims over 24 months.
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group received the intervention after a six month delay.
Number of subjects: 126
Study: 12663565

Group type: EXPERIMENTAL
Intervention: Highest quintile of sucrose intake
Number of subjects: 39345

Group type: EXPERIMENTAL
Intervention: Highest quintile of fructose intake
Number of subjects: 39345

Group type: EXPERIMENTAL
Intervention: Highest quintile of glucose intake
Number of subjects: 39345

Group type: EXPERIMENTAL
Intervention: Highest quintile of lactose intake
Number of subjects: 39345
Study: 11115000

Group type: EXPERIMENTAL
Intervention: Short hospital postnatal stay (6-48 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Longer hospital postnatal stay (more than 48 hours)
Number of subjects: 0
Study: 9124664

Group type: EXPERIMENTAL
Intervention: Fresh gas flow at levels of 0.2-3 l.min-1
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Decreasing tidal volume at a constant respiratory rate of 15 breath.min-1
Number of subjects: 12
Study: 7957519

Group type: EXPERIMENTAL
Intervention: i.v. iopromide 15 g iodine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: i.v. iopromide 80 g iodine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3474214

Group type: EXPERIMENTAL
Intervention: Suprofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 0
Study: 28229575

Group type: EXPERIMENTAL
Intervention: Low-volume plyometric training (PLYO)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Regular training sessions (CON)
Number of subjects: 29
Study: 27840340

Group type: EXPERIMENTAL
Intervention: Aerobic exercise, supervised 2 days per week for 10 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no aerobic exercise)
Number of subjects: 60
Study: 25439040

Group type: EXPERIMENTAL
Intervention: Allopathic treatment (usually paracetamol, 33.5%) and homeopathic treatment (Oscillococcinum, 56.6%)
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Allopathic treatment
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Homeopathic treatment
Number of subjects: 573
Study: 22794202

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with 1:200,000 epinephrine
Number of subjects: 60

Group type: COMPARATOR
Intervention: 2% lidocaine with 1:80,000 epinephrine
Number of subjects: 60
Study: 20018316

Group type: EXPERIMENTAL
Intervention: Escalating voltage treatment strategy (500 shocks at 14k V, 1,000 at 16 kV, and 1,000 at 18 kV)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Fixed voltage treatment strategy (2,500 shocks at 18 kV)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Escalating voltage treatment strategy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Fixed voltage treatment strategy
Number of subjects: 45
Study: 18388897

Group type: EXPERIMENTAL
Intervention: High-intensity exercise program (10 consecutive days of treadmill walking for 1 h/day at 70‐75% of peak aerobic capacity)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: High-intensity exercise program
Number of subjects: 31
Study: 16864174

Group type: EXPERIMENTAL
Intervention: Anthracycline containing chemotherapy
Number of subjects: 85
Study: 12356187

Group type: COMPARATOR
Intervention: Chronic hemodialysis patients
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Hemodialysis procedure
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Biocompatible and bioincompatible membranes
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Predialysis F2-isoprostane
Number of subjects: 18
Study: 9661609

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) at an initial dose of 50 mg daily for 5 days, increased to 100 and 150 mg daily in subsequent cycles if no response was observed.
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) treatment
Number of subjects: 201
Study: 7655768

Group type: EXPERIMENTAL
Intervention: Maxil (Hikma Pharmaceuticals, 750 mg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Zinacef (Glaxo, 750 mg)
Number of subjects: 26
Study: 2667318

Group type: EXPERIMENTAL
Intervention: Neutrons alone
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Mixed-beam therapy
Number of subjects: 49

Group type: COMPARATOR
Intervention: Photons
Number of subjects: 49
Study: 766895

Group type: EXPERIMENTAL
Intervention: Insulin (1 unit given intravenously)
Number of subjects: 7
Study: 7016781

Group type: EXPERIMENTAL
Intervention: BAY g 5421 (100 mg three times per day)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: BAY g 5421
Number of subjects: 6
Study: 31714598

Group type: EXPERIMENTAL
Intervention: Technology-based information and coaching/support program
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 115
Study: 31861457

Group type: EXPERIMENTAL
Intervention: Ophthalmologists
Number of subjects: 16

Group type: COMPARATOR
Intervention: Optometrists
Number of subjects: 16
Study: 28329381

Group type: EXPERIMENTAL
Intervention: 90‐minute nap opportunity
Number of subjects: 95

Group type: COMPARATOR
Intervention: Quiet wakefulness interval
Number of subjects: 95
Study: 25666740

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 µg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intravenous oxytocin (10 IU)
Number of subjects: 100
Study: 24506332

Group type: EXPERIMENTAL
Intervention: High cognitive load with Black patient vignette
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Low cognitive load with Black patient vignette
Number of subjects: 98
Study: 20712446

Group type: EXPERIMENTAL
Intervention: Surgical guide design (no guide, tube, channel, guided)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Experienced surgeons
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Surgical guide design
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Size of edentulous sites
Number of subjects: 21
Study: 19626807

Group type: EXPERIMENTAL
Intervention: Chlorhexidine for skin preparation (group 2)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Povidone Iodine for skin preparation (group 1)
Number of subjects: 500
Study: 17312207

Group type: EXPERIMENTAL
Intervention: bupivacaine 3 mg + fentanyl 20 mug
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: bupivacaine 7.5 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: bupivacaine 5 mg + fentanyl 20 mug
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: bupivacaine 4 mg + fentanyl 20 mug
Number of subjects: 100
Study: 14985992

Group type: EXPERIMENTAL
Intervention: Nocturnal trapezius muscle activity
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Deltoid muscle activity
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Biceps and hand flexors muscle activity
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nocturnal trapezius activity
Number of subjects: 60
Study: 12479490

Group type: EXPERIMENTAL
Intervention: Quality improvement intervention for depression treatment
Number of subjects: 938

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 938
Study: 15468432

Group type: EXPERIMENTAL
Intervention: Intramuscular ISG (4 mL every 2 months from unscreened donors)
Number of subjects: 899

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 899
Study: 7656524

Group type: EXPERIMENTAL
Intervention: Air as an insufflation agent
Number of subjects: 100

Group type: COMPARATOR
Intervention: CO2 as an insufflation agent
Number of subjects: 100
Study: 2523493

Group type: EXPERIMENTAL
Intervention: Ceftriaxone (CTRX) 1 g once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cefotiam (CTM) 2 g twice daily
Number of subjects: 0
Study: 791457

Group type: EXPERIMENTAL
Intervention: Dextran 40
Number of subjects: 0
Study: 31480062

Group type: EXPERIMENTAL
Intervention: DOACs
Number of subjects: 41

Group type: COMPARATOR
Intervention: VKAs
Number of subjects: 41
Study: 28569122

Group type: EXPERIMENTAL
Intervention: Fingolimod combined with bridging therapy (Alteplase and Mechanical Thrombectomy)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Bridging therapy (Alteplase and Mechanical Thrombectomy) alone
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Fingolimod combined with bridging therapy
Number of subjects: 98